These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

480 related items for PubMed ID: 23801011

  • 21. Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?
    Ren J, Sha A, Han D, Li P, Geng J, Ma C.
    Fertil Steril; 2014 Jul; 102(1):75-81. PubMed ID: 24746740
    [Abstract] [Full Text] [Related]

  • 22. [Clinical application of gonadotropin-releasing hormone antagonist in Chinese women undergoing controlled ovarian hyperstimulation for in vitro fertilization and embryo transfer].
    Chen SL, Yin MN, Sun L, Li H, Chen X, Song HD, He JX, Zhu L, Xing FQ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 May; 27(5):588-90. PubMed ID: 17545062
    [Abstract] [Full Text] [Related]

  • 23. [Cumulative live birth rates per oocytes retrieved cycle: evaluation of clinical outcomes of IVF/ICSI].
    Wu CX, Zhang T, Shu L, Huang J, Diao FY, Ding W, Gao Y, Wang W, Mao YD, Cui YG, Liu JY.
    Zhonghua Fu Chan Ke Za Zhi; 2018 Mar 25; 53(3):160-166. PubMed ID: 29609229
    [Abstract] [Full Text] [Related]

  • 24. Triggering ovulation with gonadotropin-releasing hormone agonist in in vitro fertilization patients with polycystic ovaries does not cause ovarian hyperstimulation syndrome despite very high estradiol levels.
    Manzanares MA, Gómez-Palomares JL, Ricciarelli E, Hernández ER.
    Fertil Steril; 2010 Mar 01; 93(4):1215-9. PubMed ID: 19200978
    [Abstract] [Full Text] [Related]

  • 25. Cumulative live birth rates after one ART cycle including all subsequent frozen-thaw cycles in 1050 women: secondary outcome of an RCT comparing GnRH-antagonist and GnRH-agonist protocols.
    Toftager M, Bogstad J, Løssl K, Prætorius L, Zedeler A, Bryndorf T, Nilas L, Pinborg A.
    Hum Reprod; 2017 Mar 01; 32(3):556-567. PubMed ID: 28130435
    [Abstract] [Full Text] [Related]

  • 26. Ultrashort gonadotropin-releasing hormone agonist combined with flexible multidose gonadotropin-releasing hormone antagonist for poor responders in in vitro fertilization/embryo transfer programs.
    Orvieto R, Kruchkovich J, Rabinson J, Zohav E, Anteby EY, Meltcer S.
    Fertil Steril; 2008 Jul 01; 90(1):228-30. PubMed ID: 17681292
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Human ovarian steroid secretion in vivo: effects of GnRH agonist versus antagonist (cetrorelix).
    Garcia-Velasco JA, Isaza V, Vidal C, Landazábal A, Remohí J, Simón C, Pellicer A.
    Hum Reprod; 2001 Dec 01; 16(12):2533-9. PubMed ID: 11726570
    [Abstract] [Full Text] [Related]

  • 29. Combined administration of gonadotropin-releasing hormone agonist with human chorionic gonadotropin for final oocyte maturation in GnRH antagonist cycles for in vitro fertilization.
    Kim CH, Ahn JW, You RM, Kim SH, Chae HD, Kang BM.
    J Reprod Med; 2014 Dec 01; 59(1-2):63-8. PubMed ID: 24597289
    [Abstract] [Full Text] [Related]

  • 30. Influence of Different Gonadotropin-releasing Hormone Agonist Administration Methods on Pregnancy Outcomes of Patients Undergoing In-vitro Fertilization-embryo Transfer.
    Wu L, Ren XL, Chen W, Huang B, Zhou YF, Jin L.
    Curr Med Sci; 2019 Jun 01; 39(3):437-441. PubMed ID: 31209816
    [Abstract] [Full Text] [Related]

  • 31. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M, Bogstad J, Bryndorf T, Løssl K, Roskær J, Holland T, Prætorius L, Zedeler A, Nilas L, Pinborg A.
    Hum Reprod; 2016 Jun 01; 31(6):1253-64. PubMed ID: 27060174
    [Abstract] [Full Text] [Related]

  • 32. A comparison of gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare protocols for poor responders undergoing in vitro fertilization.
    Berin I, Stein DE, Keltz MD.
    Fertil Steril; 2010 Feb 01; 93(2):360-3. PubMed ID: 19131055
    [Abstract] [Full Text] [Related]

  • 33. Determination of the efficiency of controlled ovarian hyperstimulation in the gonadotropin-releasing hormone agonist-suppression cycle using the initial follicle count during gonadotropin stimulation.
    Huang FJ, Chang SY, Tsai MY, Kung FT, Wu JF, Chang HW.
    J Assist Reprod Genet; 2001 Feb 01; 18(2):91-6. PubMed ID: 11285987
    [Abstract] [Full Text] [Related]

  • 34. GnRH antagonist rescue of a long-protocol IVF cycle and GnRH agonist trigger to avoid ovarian hyperstimulation syndrome: three case reports.
    Martínez F, Rodríguez DB, Buxaderas R, Tur R, Mancini F, Coroleu B.
    Fertil Steril; 2011 Jun 01; 95(7):2432.e17-9. PubMed ID: 21513932
    [Abstract] [Full Text] [Related]

  • 35. Flexibility in starting ovarian stimulation at different phases of the menstrual cycle for treatment of infertile women with the use of in vitro fertilization or intracytoplasmic sperm injection.
    Qin N, Chen Q, Hong Q, Cai R, Gao H, Wang Y, Sun L, Zhang S, Guo H, Fu Y, Ai A, Tian H, Lyu Q, Daya S, Kuang Y.
    Fertil Steril; 2016 Aug 01; 106(2):334-341.e1. PubMed ID: 27114329
    [Abstract] [Full Text] [Related]

  • 36. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study.
    Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S.
    Fertil Steril; 2011 May 01; 95(6):2029-33, 2033.e1. PubMed ID: 21371705
    [Abstract] [Full Text] [Related]

  • 37. [Comparison of gonadotropin releasing hormone agonist long protocol and gonadotropin releasing hormone antagonist protocol in infertile women].
    Ren Y, Yang S, Yang R, Li R, Chen XN, Wang HY, Ma CH, Liu P, Qiao J.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2013 Dec 18; 45(6):877-81. PubMed ID: 24343066
    [Abstract] [Full Text] [Related]

  • 38. Comparison of the GnRH agonist and antagonist protocol on the same patients in assisted reproduction during controlled ovarian stimulation cycles.
    Lai Q, Zhang H, Zhu G, Li Y, Jin L, He L, Zhang Z, Yang P, Yu Q, Zhang S, Xu JF, Wang CY.
    Int J Clin Exp Pathol; 2013 Dec 18; 6(9):1903-10. PubMed ID: 24040457
    [Abstract] [Full Text] [Related]

  • 39. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS, Joo BS, Moon SE, Lee SK, Kim KS, Koo JS.
    Fertil Steril; 2008 Dec 18; 90(6):2172-8. PubMed ID: 18439601
    [Abstract] [Full Text] [Related]

  • 40. Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study.
    Vuong TN, Ho MT, Ha TD, Phung HT, Huynh GB, Humaidan P.
    Fertil Steril; 2016 Feb 18; 105(2):356-63. PubMed ID: 26523330
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 24.